Literature DB >> 2337514

Vincristine, adriamycin and high dose steroids in myeloma complicated by renal failure.

R G Aitchison1, I A Reilly, A G Morgan, N H Russell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2337514      PMCID： PMC1971600          DOI： 10.1038/bjc.1990.171

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  4 in total

1.  Effective treatment of advanced multiple myeloma refractory to alkylating agents.

Authors:  B Barlogie; L Smith; R Alexanian
Journal:  N Engl J Med       Date:  1984-05-24       Impact factor: 91.245

2.  Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients.

Authors:  S Rota; B Mougenot; B Baudouin; M De Meyer-Brasseur; V Lemaitre; C Michel; F Mignon; E Rondeau; P Vanhille; P Verroust
Journal:  Medicine (Baltimore)       Date:  1987-03       Impact factor: 1.889

3.  Renal failure in multiple myeloma. A study of the presenting findings, response to treatment and prognosis in 26 patients.

Authors:  M Cavo; M Baccarani; P Galieni; M Gobbi; S Tura
Journal:  Nouv Rev Fr Hematol       Date:  1986

4.  Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients.

Authors:  G V Forgeson; P Selby; S Lakhani; G Zulian; C Viner; J Maitland; T J McElwain
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640
  4 in total
  1 in total

1.  Is there a role for 'modified VAD' in the treatment of multiple myeloma?

Authors:  A Agazzi; S Sammassimo; D Laszlo; Sj Liptrott; R Cascio; A Alietti; C Rabascio; P Mancuso; G Pruneri; G Martinelli
Journal:  Ecancermedicalscience       Date:  2009-06-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.